Answers are grounded in this paper and cite their sources.
Biochemical and structural analysis reveals DUF6895 epimerase activity in lasso peptide biosynthesis, indicating a conserved catalytic mechanism across neglected bacterial proteins.
The domain of unknown function 6895 (DUF6895) constitutes a poorly characterized protein family. Its functional obscurity positions this family of proteins as high-value targets to unlock cryptic enzymatic activities and molecular mechanisms. Here, we identified a DUF6895-encoding gene within a lasso peptide biosynthetic gene cluster. The DUF6895 protein ShpE functions as a distinct epimerase that inverts the configuration of phenylalanine in the linear precursor peptide, a modification essential for the subsequent tryptophan dihydroxylation. Structural and mechanistic analyses demonstrated that ShpE provides a hydrophobic cavity to accommodate phenylalanine and employs acid–base chemistry to facilitate reversible epimerization via dual His/Glu catalytic dyads. These dyads are evolutionarily conserved across DUF6895 proteins, suggesting the majority of these family members function as epimerases through a common molecular mechanism. Our work on ShpE expands the enzymatic repertoire for epimerization in ribosomally synthesized and post-translationally modified peptides (RiPPs), providing crucial insights into the function and mechanism of the neglected DUF6895 proteins.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: